Oxidative stress plays a major role in development of
cardiovascular disease in patients with
chronic kidney disease (CKD). Human
mercaptalbumin (HMA), a reduced form of
serum albumin, and non-
mercaptalbumin (HNA), an oxidized form of
serum albumin, are known as indicators for evaluating oxidative stress in systemic circulation, including
end-stage renal disease cases. We investigated factors associated with fraction of HNA [f(HNA)] in 112 pre-dialysis CKD patients (63.6 ± 14.0 years old; 59 males, 53 females) using a newly established
anion-exchange column packed with hydrophilic
polyvinyl alcohol gel as well as high performance liquid chromatography. Mean f(HNA) in our CKD patients was 30.0 ± 6.1%, higher than that previously reported for healthy subjects. In multiple regression analysis, age (β = 0.200, p = 0.014), eGFR (β = -0.238, p = 0.009),
hemoglobin (β = -0.346, p < 0.001), and
ferritin (β = 0.200, p = 0.019) were significantly and independently associated with f(HNA) (R2 = 0.356, p < 0.001). In addition, factors related to CKD-
mineral and bone disorder (
CKD-MBD), including intact-PTH (β = 0.218, p = 0.049) and
1,25-dihydroxyvitamin D (1,25(
OH)2D) (β = -0.178, p = 0.040), were significantly and independently associated with serum f(HNA) (R2 = 0.339, p < 0.001), whereas
fibroblast growth factor-23 was not. These findings indicate the importance of management of
hemoglobin and
ferritin levels, as well as appropriate control of
CKD-MBD factors for a better redox state of
serum albumin in CKD patients.